Ick Chan Kwon

Active 1991–2025

164
Papers
29,449
Citations
102
h-index
162
i10-index

Citations

Citations per year for Ick Chan Kwon1993: 11 citations1994: 2 citations1995: 4 citations1996: 2 citations1997: 4 citations1998: 3 citations1999: 11 citations2000: 12 citations2001: 21 citations2002: 20 citations2003: 44 citations2004: 54 citations2005: 86 citations2006: 91 citations2007: 101 citations2008: 170 citations2009: 226 citations2010: 332 citations2011: 392 citations2012: 423 citations2013: 408 citations2014: 442 citations2015: 446 citations2016: 392 citations2017: 388 citations2018: 407 citations2019: 967 citations2020: 996 citations2021: 1,007 citations2022: 875 citations2023: 726 citations2024: 832 citations2025: 486 citations2026: 9 citations

Citation sources

Countries

World map of the countries and regions citing this authorChina: 3,233 citing papers, 29.7% of this breakdownUnited States: 1,748 citing papers, 16.1% of this breakdownSouth Korea: 818 citing papers, 7.5% of this breakdownIndia: 633 citing papers, 5.8% of this breakdownIran: 341 citing papers, 3.1% of this breakdownUnited Kingdom: 270 citing papers, 2.5% of this breakdownAustralia: 227 citing papers, 2.1% of this breakdownItaly: 215 citing papers, 2% of this breakdownGermany: 192 citing papers, 1.8% of this breakdownFrance: 187 citing papers, 1.7% of this breakdownJapan: 181 citing papers, 1.7% of this breakdownSingapore: 180 citing papers, 1.7% of this breakdown
0%29.7%Other 24.3%

Fields

  • Biochemistry, Genetics and Molecular Biology29.6%
  • Materials Science23.8%
  • Engineering17.4%
  • Medicine14.9%
  • Pharmacology, Toxicology and Pharmaceutics5.5%
  • Immunology and Microbiology3.8%
  • Other5%

Topics

  • Nanoparticle-Based Drug Delivery9.8%
  • Nanoplatforms for cancer theranostics8.9%
  • RNA Interference and Gene Delivery7.8%
  • Advanced biosensing and bioanalysis techniques5.4%
  • Advanced Drug Delivery Systems4.3%
  • Hydrogels: synthesis, properties, applications2.6%
  • Other61.2%

Coauthors

All papers

Open in search
  1. Exosome‐Guided Phenotypic Switch of M1 to M2 Macrophages for Cutaneous Wound Healing

    Authors: , , , , , - Advanced Science 2019 cited by 549

  2. Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment

    Authors: , , , , , - Theranostics 2019 cited by 363

  3. Fine tuning of CpG spatial distribution with DNA origami for improved cancer vaccination

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Nanotechnology 2024 cited by 156

  4. Multifunctional nanoparticles for multimodal imaging and theragnosis

    Authors: , , , , , - Chemical Society Reviews 2011 cited by 1,393

  5. The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection

    Authors: , , , , , , , , , , - Biomaterials 2012 cited by 207

  6. Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy

    Authors: , , , , , , , , , , , , - Journal of Controlled Release 2018 cited by 169

  7. Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer

    Authors: , , , , , , , , , , , , , , , , - Bioactive Materials 2022 cited by 55

  8. Tumor‐Targeting Glycol Chitosan Nanoparticles for Cancer Heterogeneity

    Authors: , , , , - Advanced Materials 2020 cited by 138

  9. Molecularly engineered siRNA conjugates for tumor-targeted RNAi therapy

    Authors: , , , , , , , - Journal of Controlled Release 2022 cited by 55

  10. Bioorthogonally surface‐edited extracellular vesicles based on metabolic glycoengineering for CD44‐mediated targeting of inflammatory diseases

    Authors: , , , , , , , , , , , , , , , , , - Journal of Extracellular Vesicles 2021 cited by 75

  11. Long-Circulating Au-TiO2Nanocomposite as a Sonosensitizer for ROS-Mediated Eradication of Cancer

    Authors: , , , , , , , , , , , - Nano Letters 2016 cited by 401

  12. Development of Biocompatible HA Hydrogels Embedded with a New Synthetic Peptide Promoting Cellular Migration for Advanced Wound Care Management

    Authors: , , , , , , , , - Advanced Science 2018 cited by 114

  13. Targeted delivery of low molecular drugs using chitosan and its derivatives

    Authors: , , , - Advanced Drug Delivery Reviews 2009 cited by 816

  14. Dextran sulfate nanoparticles as a theranostic nanomedicine for rheumatoid arthritis

    Authors: , , , , , , , , , , , , , , - Biomaterials 2017 cited by 196

  15. Xenogenization of tumor cells by fusogenic exosomes in tumor microenvironment ignites and propagates antitumor immunity

    Authors: , , , , , , , - Science Advances 2020 cited by 63

  16. Targeted delivery of anti-inflammatory cytokine by nanocarrier reduces atherosclerosis in Apo E−/- mice

    Authors: , , , , , , , - Biomaterials 2019 cited by 120

  17. Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery

    Authors: , , , , , , , , , , , , - Biomaterials 2013 cited by 352

  18. Notch1 targeting siRNA delivery nanoparticles for rheumatoid arthritis therapy

    Authors: , , , , , , , , , , , , - Journal of Controlled Release 2015 cited by 119

  19. Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade

    Authors: , , , , - Advanced Drug Delivery Reviews 2024 cited by 80

  20. Self-assembled hyaluronic acid nanoparticles for active tumor targeting

    Authors: , , , , , , , - Biomaterials 2009 cited by 568

  21. TNF-α Gene Silencing Using Polymerized siRNA/Thiolated Glycol Chitosan Nanoparticles for Rheumatoid Arthritis

    Authors: , , , , , , , , , , , , - Molecular Therapy 2013 cited by 159

  22. Development of microRNA-21 mimic nanocarriers for the treatment of cutaneous wounds

    Authors: , , , , , , , , - Theranostics 2020 cited by 59

  23. Smart Nanocarrier Based on PEGylated Hyaluronic Acid for Cancer Therapy

    Authors: , , , , , , , , , , , - ACS Nano 2011 cited by 395

  24. A Trojan-Horse Strategy by In Situ Piggybacking onto Endogenous Albumin for Tumor-Specific Neutralization of Oncogenic MicroRNA

    Authors: , , , , , , , , , - ACS Nano 2021 cited by 38